The Effectiveness of E-health Intervention in Improving Mental Health Outcomes Among Breast Cancer Patients
Launched by NATIONAL UNIVERSITY OF MALAYSIA · Aug 19, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective digital health tools, known as e-health interventions, can help breast cancer patients improve their mental health. The study aims to encourage these patients, aged 18 to 65, to seek support for issues like depression and anxiety by making mental health resources more accessible online. Researchers will compare the experiences of patients using these digital tools with those receiving traditional care, to see if the e-health approach can change how patients think about and pursue mental health support.
To participate in the study, patients must be undergoing treatment for breast cancer at Institut Kanser Negara (IKN) and be comfortable understanding information in Malay or English. Patients with brain metastasis, those diagnosed with a mental illness, or those with a poor performance status (meaning they have significant health issues) are not eligible. Participants can expect to engage with helpful online resources and share their experiences, contributing to important research that could improve mental health care for breast cancer patients in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Breast cancer patients from all stages of the disease who are currently undergoing treatment at Institut Kanser Negara (IKN)
- • Age 18 years and above
- • Patients willing to participate
- • Patients understand either Malay or English language
- Exclusion Criteria:
- • Patients with breast cancer and metastasis to the brain
- • Patients who are diagnosed with mental illness
- • Patients with performance status 3 and above (based on The Eastern Cooperative Oncology Group (ECOG) Scale of Performance Status)
About National University Of Malaysia
The National University of Malaysia (Universiti Kebangsaan Malaysia, UKM) is a prestigious institution dedicated to advancing medical research and clinical trials that contribute significantly to the fields of healthcare and biomedical sciences. As a leading academic and research university, UKM is committed to fostering innovation and excellence in clinical research, promoting collaboration among multidisciplinary teams, and enhancing the quality of patient care. The university's robust infrastructure and experienced research faculty facilitate rigorous clinical trials aimed at addressing critical health challenges, thereby improving health outcomes both locally and globally. Through its dedication to ethical research practices and adherence to regulatory standards, UKM strives to enhance the understanding of diseases and develop effective interventions that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Putrajaya, , Malaysia
Patients applied
Trial Officials
Azmawati Mohammed Nawi
Principal Investigator
The National University of Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported